Maintenance and reversibility of natural killer cell- and T cell- independent B lymphocyte xenotolerance in athymic nude rats

Transplantation

Volumn 68, Issue 8, 1999, Pages 1181-1188

  Xia, Guliang ^b   Ji, Ping ^b   Rutgeerts, Omer ^b   Waer, Mark ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 2; LEFLUNOMIDE;

ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CELL INFILTRATION; COMPLEMENT FACTOR; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HEART GRAFT; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ANIMALS; ANTIGENS, HETEROPHILE; B-LYMPHOCYTES; CRICETINAE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; KILLER CELLS, NATURAL; MESOCRICETUS; MICE; MICE, INBRED BALB C; MYOCARDIUM; RATS; RATS, NUDE; T-LYMPHOCYTES; TIME FACTORS; TRANSPLANTATION CONDITIONING;

EID: 0033610494     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199910270-00019     Document Type: Article

References (39)

1. Auchincloss H Jr., Sachs DH. Xenogeneic transplantation. Annu Rev Immunol 1998; 16: 433.
2. Lin Y, Vadeputte M, Waer M. Natural killer cell-and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell response. J Immunol 1997; 158: 5658.
3. Hougen HP. The athymic nude rat: immunological characteristics with special reference to establishment of non-antigen-specific T cell reactivity and induction of antigen-specific immunity. APMIS Suppl 1991; 99: 9.
4. Najarian JS. Overview of in vivo xenotransplantation studies: prospects for the future. Transplant Proc 1992; 24: 733.
5. Thomas FT, Marchman W, Carobbi A, Araneda CD, Pryor W, Thomas J. Immunobiology of the xenograft response: xenograft rejection in immunodeficient animals. Transplant Proc 1991; 23: 208.
6. Lin Y, Goebels J, Xia GL, Ji P, Vandeputte M, Waer M. Induction of specific transplantation tolerance across xenogeneic barriers in the T-independent immune compartment. Nat Med 1998; 4: 173.
7. Ono K, Lindsy ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969; 57: 225.
8. Reynolds CW, Timonen TT, Holden HT, Hansen CT, Herberman RB. Natural killer cell activity in the rat: analysis of effector cell morphology and effects of interferon on natural killer function in the athymic nude rat. Eur J Immunol 1982; 12: 577.
9. Rolstad B, Vaage JT, Naper C, Lambracht D, Wonigeit K, Joly E, et al. Positive and negative MHC class I recognition by rat NK cells. Immunol Rev 1997; 155: 91.
10. Rolstad B, Seaman WE. Natural killer cells and recognition of MHC class I molecules: new perspective and challenges in immunology. Scand J Immunol 1998; 47: 412.
11. Inverardi L, Samaja M, Motterlini R, Mangili F, Bender JR, Pardi R. Early recognition of a discordant xenogeneic organ by human circulating lymphocytes. J Immunol 1992; 149: 1416.
12. Goodman D, von Albertini M, Wilson A, Millan MT, Bach FH. Direct activation of porcine endothelial cells by human natural killer cells. Transplantation 1996; 61: 763.
13. Torgersen KM, Salcedo M, Vaage JT, Naper C, Rolstad B, Ljunggren HG, et al. Major histocompatibility complex class I-independent killing of xenogeneic targets by rat allospecific natural killer cells. Transplantation 1997; 63: 119.
14. Seebach JD, Comrack C, Germana S, LeGuern C, Sachs DH, derSimonian H. HLA-cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells. J Immunol 1997; 159: 3635.
15. Munz C, Holmes N, King A, Loke YW, Colonna M, Schild H, et al. Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. J Exp Med 1997; 185: 385.
16. Raulet DH, Held W, Correa I, Dorfman JR, Wu MF, Corral L. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol Rev 1997; 155: 41.
17. Dorfman JR, Raulet DH. Acquisition of Ly49 receptor expression by developing natural killer cells. J Exp Med 1998; 187: 609.
18. Manoussaka MS, Smith RJ, Conlin V, Toomey JA, Brooks CG. Fetal mouse NK clones are deficient in Ly49 expression, share a common broad lytic specificity and undergo continuous and extensive diversification in vitro. J Immunol 1998; 160: 2197.
19. Cook JL, Ikle DN, Routes BA. Natural killer cell ontogeny in the athymic rat: relationship between functional maturation and acquired resistance to E1A oncogene-expressing sarcoma cells. J Immunol 1995; 155: 5512.
20. Kung SKP, Miller RG. Mouse natural killer subsets defined by their target specificity and their ability to be separately rendered unresponsive in vivo. J Immunol 1997; 158: 2616.
21. Johansson MH, Bieberich C, Jay G, Karre K, Hoglund P. Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex I transgene. J Exp Med 1997; 186: 353.
22. Karlhofer FM, Hunziker R, Reichlin A, Margulies DH, Yokoyama WM. Host MHC class I molecules modulate in vivo expression of a NK receptor. J Immunol 1994; 153: 2407.
23. Wu MF, Raulet DH. Class I-deficient hematopoietic cells and nonhematopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts. J Immunol 1997; 158: 1628.
24. Salcedo M, Diehl AD, Olsson-Alheim MY, Sunback J, Kaer LV, Karre K, et al. Altered expression of Ly49 inhibitory receptors on natural killer cells from MHC class I-deficient mice. J Immunol 1997; 158: 3174.
25. Sentman CL, Olsson MY, Karre K. Missing self recognition by natural killer cells in MHC class I trangeneic mice. A "receptor calibration" model for how effector cells adapt to self. Semin Immunol 1995; 7: 109.
26. low NK cells. J Immunol 1997; 159: 3189.
27. Bendelac A. Selection and adaptation of cells expressing major histocompatibility complex class I-specific receptors of the natural killer complex. J Exp Med 1997; 186: 349.
28. Held W, Raulet DH. Ly49A transgeneic mice provide evidence for a major histocompatibility complex-dependent education process in natural killer cell development. J Exp Med 1997; 185: 2079.
29. Vaage JT, Reynolds D, Fossum S, Rolstad B. The proliferation and life-span of rat large granular lymphocytes: effects of cytokines. Eur J Immunol 1989; 19: 1895.
30. Whalen BJ, Goldschneider I. Identification of B cell precursors in rat lymphoid tissues. Cell Immunol 1993; 151: 168.
31. Dallman MJ, Thomas ML, Green JR. MRC OX-19: a monoclonal antibody that labels rat T lymphocytes and augments in vitro proliferative response. Eur J Immunol 1984; 14: 260.
32. + B cells in the thymus of estradiol benzoate-treated rats. Thymus 1996; 24: 111.
33. Lin Y, Vadeputte M, Waer M. Suppression of T-independent IgM xenoantibody formation by leflunomide during xenografting of hamster hearts in rats. Transplantation 1998; 65: 332.
34. Turman MA, Casali P, Notkins AL. Polyreactivity and antigen specificity of human xenoreactive monoclonal and serum natural antibodies. Transplantation 1991; 52: 710.
35. Langer A, Valdivia LA, Murase N, Woo J, Fung JJ, Starzl TE, et al. Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Am J Pathol 1993; 143: 85.
36. Yang YG, DeGoma E, Barth R, Sergio JJ, Sykes M. B-cell reconstitution and xenoreactive anti-pig natural antibody production in severe combined immunodeficient mice reconstituted with immunocompetent B cells from varying sources. Transplantation 1998; 66: 89.
37. Wakiyama S, Cramer DV, Wu GD, Swensson J, Gochi E, Mendez R. Analysis of B cell subsets responsible for the production of anti-donor antibodies in hamster-to-rat xenorejection. Transplant Proc 1998; 30: 1085.
38. Waer M. Leflunomide, malononitriloamides and transplantation immunology. Transplant Rev 1998; 12: 156.
39. + B-cell subset. Semin Immunol 1996; 8: 37.